Ki Cheong Park is the chief scientific officer of CKP. He received his Ph.D. in oncology at the Yonsei University College of Medicine, a leading medical school in South Korea. Dr. Park has active research covering topics including cancer stem cells, epigenetics & drug targets, and patient-derived cancer therapies, and over two decades in medical experience. His main research focuses on overcoming drug resistance by targeting cancer stem cells. Past funders for his research projects include the Korean Ministry of Education and the Korean Ministry of Health & Welfare.